Point-Of-Care-Testing (POCT) Global Market Report 2026

Description

Point-of-care testing (POCT) refers to diagnostic testing conducted at or near the site of patient care, providing immediate results and enabling faster clinical decision-making. Its purpose is to deliver quick and accurate diagnostic information directly at the point of care, facilitating timely treatment and improved patient outcomes.

The primary types of point-of-care testing (POCT) include blood glucose testing, infectious disease testing, cardiac marker testing, coagulation testing, pregnancy and fertility testing, blood gas or electrolyte testing, urinalysis testing, and others. Blood glucose testing involves measuring the amount of sugar (glucose) in a person's blood to monitor and manage related conditions. POCT products are available through various purchase modes, including over-the-counter and prescription-based products, and utilize technologies such as immunoassays, molecular diagnostics, microbial detection, polymerase chain reaction (PCR) testing, and biochemical testing. Key end users include clinical laboratories, ambulatory care facilities, physician offices, pharmacies, retail clinics, e-commerce platforms, hospitals, critical care centers, urgent care centers, home care and self-testing, and others.

Tariffs have influenced the point-of-care testing market by increasing costs of imported diagnostic devices, reagents, and electronic components used in POCT systems. Segments such as molecular diagnostics, PCR testing, and immunoassay-based devices are most affected, particularly in Asia-Pacific and North America where cross-border trade of medical diagnostics is high. These cost pressures have impacted pricing and slowed adoption in cost-sensitive markets. However, tariffs have also encouraged local manufacturing, regional supply chain development, and innovation in cost-effective POCT solutions.

The point-of-care-testing (poct) market research report is one of a series of new reports from The Business Research Company that provides point-of-care-testing (poct) market statistics, including point-of-care-testing (poct) industry global market size, regional shares, competitors with a point-of-care-testing (poct) market share, detailed point-of-care-testing (poct) market segments, market trends and opportunities, and any further data you may need to thrive in the point-of-care-testing (poct) industry. This point-of-care-testing (poct) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The point-of-care-testing (poct) market size has grown rapidly in recent years. It will grow from $50.79 billion in 2025 to $56.68 billion in 2026 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing need for rapid clinical decision making, growth in emergency and critical care services, limited access to centralized laboratories, demand for immediate diagnostic results.

The point-of-care-testing (poct) market size is expected to see rapid growth in the next few years. It will grow to $86.91 billion in 2030 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to advancement in poct device miniaturization, expansion of home care and remote patient monitoring, growing infectious disease outbreaks, increasing healthcare decentralization, rising adoption of self-testing diagnostics. Major trends in the forecast period include growing adoption of rapid diagnostic testing at point of care, rising demand for home-based and self-testing solutions, expansion of over-the-counter diagnostic products, increasing focus on early disease detection and screening, improved accuracy and sensitivity of poct devices.

The growing adoption of telemedicine is expected to drive the growth of the point-of-care testing (POCT) market in the coming years. Telemedicine involves delivering medical care remotely using digital communication technologies such as video calls, phone consultations, or secure messaging. Its adoption has accelerated due to rising demand for convenient, timely, and contact-free healthcare services, particularly following the COVID-19 pandemic. POCT supports telemedicine by providing rapid and reliable diagnostic results that can be shared instantly with remote healthcare providers, enabling timely clinical decisions. For example, in April 2025, the American Hospital Association, a U.S.-based professional organization, reported that in 2023, over 12.6% of Medicare beneficiaries utilized telehealth services. By 2036, the number of physicians is projected to reach 86,000, highlighting telehealth's crucial role in addressing the growing physician shortage. Consequently, the increasing adoption of telemedicine is fueling the growth of the POCT market.

Major companies in the point-of-care testing (POCT) market are increasingly emphasizing technological innovations, such as microfluidic rapid antimicrobial-susceptibility testing (AST) systems, to meet the growing demand for faster, clinic-level diagnostics and enhanced antimicrobial stewardship in primary care. Microfluidic AST technology uses micrometer-scale fluid channels to culture and detect bacteria from patient samples-such as urine-and determine their antibiotic susceptibility far more quickly than conventional culture-based methods, which typically take several days. For instance, in June 2023, Sysmex Corporation, a Japan-based diagnostics company, launched the PA 100 AST System, a compact POCT analyzer that uses Sysmex Astrego's proprietary microfluidic cartridges to detect bacteria in roughly 15 minutes and deliver complete AST results in about 30 minutes. The system is highly user-friendly: healthcare professionals place the sample into a single-use cartridge, insert it into the desktop analyzer, and receive automated AST readouts without requiring specialized laboratory training. This rapid turnaround enables timely antibiotic decisions during the initial patient visit, supporting efforts to reduce inappropriate prescriptions and combat antimicrobial resistance (AMR).

In August 2024, Quest Diagnostics Inc., a US-based medical laboratory company, acquired LifeLabs LP for $1 billion (CAN $1.35 billion). This acquisition expands Quest Diagnostics' POCT offerings and strengthens access to innovative diagnostic solutions. LifeLabs LP is a Canada-based provider of point-of-care testing services.

Major companies operating in the point-of-care-testing (poct) market are Johnson & Johnson, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY, Accriva, ACON Laboratories, Sekisui Diagnostics, PTS Diagnostics, Meridian Bioscience

North America was the largest region in the point-of-care testing (POCT) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the point-of-care-testing (poct) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the point-of-care-testing (poct) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The point-of-care testing (POCT) market includes revenues earned by entities by providing services such as on-site diagnostic testing, rapid disease detection, mobile health screening, and patient self-testing support. The market value includes the value of related goods sold by the service provider or included within the service offering. The point-of-care testing (POCT) market includes sales of portable HbA1c analyzers, handheld blood gas analyzers, CRP (C-reactive protein) test kits, multiplex respiratory pathogen detection kits, and lateral flow urine analysis devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Point-Of-Care-Testing (POCT) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses point-of-care-testing (poct) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for point-of-care-testing (poct) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The point-of-care-testing (poct) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type: Blood Glucose Testing; Infectious Diseases Testing; Cardiac Markers Testing; Coagulation Testing; Pregnancy And Fertility Testing; Blood Gas Or Electrolytes Testing; Urinalysis Testing; Other Types
2) By Mode Of Purchase: Over-The-Counter Products; Prescribed Based Products
3) By Technology: Immunoassays; Molecular Diagnostics; Microbial Detection; Polymerase Chain Reaction (PCR) Testing; Biochemical Testing
4) By End-User: Clinical Laboratories; Ambulatory Care Facilities And Physician Offices; Pharmacies; Retail Clinics And E-Comm Platforms; Hospitals; Critical Care Centres; Urgent Care Centres; Home Care And Self-Testing; Other End-Users
Subsegments:
1) By Blood Glucose Testing: Self-Monitoring Blood Glucose Devices; Continuous Glucose Monitoring Devices; Flash Glucose Monitoring Devices
2) By Infectious Diseases Testing: Human Immunodeficiency Virus (HIV) Testing; Hepatitis Testing; Influenza Testing; COVID-19 Testing; Other Infectious Diseases Testing
3) By Cardiac Markers Testing: Troponin Testing; Creatine Kinase-MB (CK-MB) Testing; Myoglobin Testing; B-type Natriuretic Peptide (BNP) Testing
4) By Coagulation Testing: Prothrombin Time (PT) Testing; Activated Partial Thromboplastin Time (aPTT) Testing; International Normalized Ratio (INR) Testing
5) By Pregnancy And Fertility Testing: Pregnancy Test Kits; Ovulation Test Kits; Fertility Hormone Testing
6) By Blood Gas Or Electrolytes Testing: Arterial Blood Gas Testing; Venous Blood Gas Testing; Electrolyte Testing
7) By Urinalysis Testing: Urine Chemistry Analysis; Microscopic Urine Analysis; Urine Culture Testing
8) By Other Types: Drug Abuse Testing; Allergy Testing; Cholesterol Testing; Thyroid Function Testing
Companies Mentioned: Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; BioMerieux SA; QuidelOrtho Corporation; Sysmex Corporation; Nova Biomedical Corporation; LifeScan Inc.; Ascensia Diabetes Care Holdings AG; Trividia Health Inc.; Trinity Biotech Plc; Sinocare Inc.; Menarini Diagnostics; Princeton BioMeditech; Helena Laboratories; Chembio Diagnostics; ARKRAY; Accriva; ACON Laboratories; Sekisui Diagnostics; PTS Diagnostics; Meridian Bioscience
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: ME4MPOCT02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Point-Of-Care-Testing (POCT) Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Point-Of-Care-Testing (POCT) Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Point-Of-Care-Testing (POCT) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Point-Of-Care-Testing (POCT) Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Artificial Intelligence & Autonomous Intelligence
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.4 Biotechnology, Genomics & Precision Medicine
- 4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
- 4.2.1 Growing Adoption Of Rapid Diagnostic Testing At Point Of Care
- 4.2.2 Rising Demand For Home-Based And Self-Testing Solutions
- 4.2.3 Expansion Of Over-The-Counter Diagnostic Products
- 4.2.4 Increasing Focus On Early Disease Detection And Screening
- 4.2.5 Improved Accuracy And Sensitivity Of Poct Devices

5. Point-Of-Care-Testing (POCT) Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Clinical Laboratories
5.3 Ambulatory Care Facilities And Physician Offices
5.4 Home Care And Self-Testing Users
5.5 Pharmacies

6. Point-Of-Care-Testing (POCT) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Point-Of-Care-Testing (POCT) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Point-Of-Care-Testing (POCT) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Point-Of-Care-Testing (POCT) Market Size, Comparisons And Growth Rate Analysis
7.3. Global Point-Of-Care-Testing (POCT) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Point-Of-Care-Testing (POCT) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Point-Of-Care-Testing (POCT) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Point-Of-Care-Testing (POCT) Market Segmentation

9.1. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Pregnancy And Fertility Testing, Blood Gas Or Electrolytes Testing, Urinalysis Testing, Other Types
9.2. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Over-The-Counter Products, Prescribed Based Products
9.3. Global Point-Of-Care-Testing (POCT) Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Immunoassays, Molecular Diagnostics, Microbial Detection, Polymerase Chain Reaction (PCR) Testing, Biochemical Testing
9.4. Global Point-Of-Care-Testing (POCT) Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Clinical Laboratories, Ambulatory Care Facilities And Physician Offices, Pharmacies, Retail Clinics And E-Comm Platforms, Hospitals, Critical Care Centres, Urgent Care Centres, Home Care And Self-Testing, Other End-Users
9.5. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Glucose Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Flash Glucose Monitoring Devices
9.6. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Infectious Diseases Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Human Immunodeficiency Virus (HIV) Testing, Hepatitis Testing, Influenza Testing, COVID-19 Testing, Other Infectious Diseases Testing
9.7. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Cardiac Markers Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Troponin Testing, Creatine Kinase-MB (CK-MB) Testing, Myoglobin Testing, B-type Natriuretic Peptide (BNP) Testing
9.8. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Coagulation Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Prothrombin Time (PT) Testing, Activated Partial Thromboplastin Time (aPTT) Testing, International Normalized Ratio (INR) Testing
9.9. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Pregnancy And Fertility Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pregnancy Test Kits, Ovulation Test Kits, Fertility Hormone Testing
9.10. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Blood Gas Or Electrolytes Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Arterial Blood Gas Testing, Venous Blood Gas Testing, Electrolyte Testing
9.11. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Urinalysis Testing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Urine Chemistry Analysis, Microscopic Urine Analysis, Urine Culture Testing
9.12. Global Point-Of-Care-Testing (POCT) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Drug Abuse Testing, Allergy Testing, Cholesterol Testing, Thyroid Function Testing

10. Point-Of-Care-Testing (POCT) Market Regional And Country Analysis

10.1. Global Point-Of-Care-Testing (POCT) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Point-Of-Care-Testing (POCT) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Point-Of-Care-Testing (POCT) Market

11.1. Asia-Pacific Point-Of-Care-Testing (POCT) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Point-Of-Care-Testing (POCT) Market

12.1. China Point-Of-Care-Testing (POCT) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Point-Of-Care-Testing (POCT) Market

13.1. India Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Point-Of-Care-Testing (POCT) Market

14.1. Japan Point-Of-Care-Testing (POCT) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Point-Of-Care-Testing (POCT) Market

15.1. Australia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Point-Of-Care-Testing (POCT) Market

16.1. Indonesia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Point-Of-Care-Testing (POCT) Market

17.1. South Korea Point-Of-Care-Testing (POCT) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Point-Of-Care-Testing (POCT) Market

18.1. Taiwan Point-Of-Care-Testing (POCT) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Point-Of-Care-Testing (POCT) Market

19.1. South East Asia Point-Of-Care-Testing (POCT) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Point-Of-Care-Testing (POCT) Market

20.1. Western Europe Point-Of-Care-Testing (POCT) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Point-Of-Care-Testing (POCT) Market

21.1. UK Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Point-Of-Care-Testing (POCT) Market

22.1. Germany Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Point-Of-Care-Testing (POCT) Market

23.1. France Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Point-Of-Care-Testing (POCT) Market

24.1. Italy Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Point-Of-Care-Testing (POCT) Market

25.1. Spain Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Point-Of-Care-Testing (POCT) Market

26.1. Eastern Europe Point-Of-Care-Testing (POCT) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Point-Of-Care-Testing (POCT) Market

27.1. Russia Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Point-Of-Care-Testing (POCT) Market

28.1. North America Point-Of-Care-Testing (POCT) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Point-Of-Care-Testing (POCT) Market

29.1. USA Point-Of-Care-Testing (POCT) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Point-Of-Care-Testing (POCT) Market

30.1. Canada Point-Of-Care-Testing (POCT) Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Point-Of-Care-Testing (POCT) Market

31.1. South America Point-Of-Care-Testing (POCT) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Point-Of-Care-Testing (POCT) Market

32.1. Brazil Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Point-Of-Care-Testing (POCT) Market

33.1. Middle East Point-Of-Care-Testing (POCT) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Point-Of-Care-Testing (POCT) Market

34.1. Africa Point-Of-Care-Testing (POCT) Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Point-Of-Care-Testing (POCT) Market, Segmentation By Type, Segmentation By Mode Of Purchase, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Point-Of-Care-Testing (POCT) Market Regulatory and Investment Landscape

36. Point-Of-Care-Testing (POCT) Market Competitive Landscape And Company Profiles

36.1. Point-Of-Care-Testing (POCT) Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Point-Of-Care-Testing (POCT) Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Point-Of-Care-Testing (POCT) Market Company Profiles
- 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Point-Of-Care-Testing (POCT) Market Other Major And Innovative Companies

Becton Dickinson and Company, BioMerieux SA, QuidelOrtho Corporation, Sysmex Corporation, Nova Biomedical Corporation, LifeScan Inc., Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Trinity Biotech Plc, Sinocare Inc., Menarini Diagnostics, Princeton BioMeditech, Helena Laboratories, Chembio Diagnostics, ARKRAY

38. Global Point-Of-Care-Testing (POCT) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Point-Of-Care-Testing (POCT) Market

40. Point-Of-Care-Testing (POCT) Market High Potential Countries, Segments and Strategies

40.1 Point-Of-Care-Testing (POCT) Market In 2030 - Countries Offering Most New Opportunities
40.2 Point-Of-Care-Testing (POCT) Market In 2030 - Segments Offering Most New Opportunities
40.3 Point-Of-Care-Testing (POCT) Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer